ArticleTherapeutic advances in gastroenterology2025
Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study.
Joana Torres et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.